Skip to main content
Equibles

HQL · abrdn Life Sciences Investors · Metrics

Track HQL — free

Use HQL with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research HQL.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$18.00 +0.30 (+1.69%) At close · Oct 27
Rebalance outlook locked
Market Cap
$547.34M
Shares
30.41M
Volume · Oct 27 166.85K Avg daily vol (3M) 137.57K

HQL metrics

41 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$18.00
Market cap
$547.34M

Price action

20 metrics
Price change (1W)
+1.2%
Price change (30D)
-4.8%
Price change (3M)
-7.1%
Price change (6M)
+2.7%
Price change (YTD)
+7.3%
Price change (1Y)
+3.7%
Trailing year
Price change (5Y)
-14.8%
52-week high
$22.67
52-week low
$15.87
Change from 52-week high
-20.6%
Change from 52-week low
+13.4%
Annualized volatility
24.3%
Annualized volatility (3M)
28.2%
Beta
0.8
RSI (14D)
47.8
Price vs SMA 50
-6.9%
Price vs SMA 200
-1.2%
Avg volume (3M)
137,568
Relative volume
1.2
Average dollar volume
$2.71M

Company

3 metrics
Sector
Financial Services
Industry
Asset Management
Shares outstanding
30.41M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
12.4%
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
$2.24
Dividend growth YoY
+23.1%
Dividend growth streak
0
Last ex-dividend
2026-08-24

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
—
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
—
Debt / equity
—
Current ratio
—
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
—
Total assets
—
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
84
13F filer change QoQ
-3
Institutional ownership
25.9%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-9.3%
Holder tenure
17.6
Price vs estimated holder cost
+31.5%

Ownership (registered funds)

1 metrics
Index-fund ownership
2.7%

Short interest

3 metrics
Short interest
0.6%
Latest settlement · 1.4 days to cover
Days to cover
1.4d
Short-squeeze score
41 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 884121 CUSIP 87911K100 13F (30d) 19 filings 19 filers Investor relations